“These outcomes have essential implications,” mentioned examine co-author Shyam Raman. He’s a doctoral scholar within the College of Public Coverage at Cornell College in Ithaca, N.Y.
“The reductions in drug utilization that we discover may result in vital price financial savings for state Medicaid applications. The outcomes additionally point out a chance to cut back the hurt that may include the damaging negative effects related to some pharmaceuticals,” Raman mentioned in a college information launch.
For the examine, the researchers analyzed U.S. Facilities for Medicare and Medicaid Providers knowledge collected from all states from 2011 to 2019, when there was a rise in states that let private marijuana use.
Presently, leisure marijuana use is authorized in 18 states plus Washington, D.C. Thirty-seven states plus Washington, D.C., have legalized medical marijuana.
Most earlier analysis has targeted on how medical marijuana impacts prescription drug use or how authorized leisure pot use impacts opioid demand. This is without doubt one of the first papers to look at the affect of authorized leisure marijuana on prescription drug use, the examine authors famous.
Whereas there’s a optimistic facet to their findings, the investigators warned that marijuana use carries dangers, pointing to various research that join it with attainable triggering of tension and psychoses reminiscent of schizophrenia.
There’s additionally the prospect that individuals who use marijuana to deal with their well being issues could not see their physician as usually, leading to gaps of their main care, the researchers mentioned.
The examine was revealed April 15 within the journal Well being Economics .
There’s extra on marijuana on the U.S. Nationwide Institute on Drug Abuse.
SOURCE: Cornell College, information launch, April 18, 2022